Shares of Australian specialty pharma firm Mayne Pharma Group (ASX: MYX) closed up 9.2% at A$3.68 today, after it released full-year fiscal 2023 financials, showing that reported revenues were A$183.6 million (US$118.5 million), up 17% on FY 2022.Reported gross profit was also up 17% at A$83.5 million, with net loss after tax coming in at A$317.4 million, compared with A$220.1 million the previous yearMayne says it has successfully refocused the company around core businesses with the exclusive US license to a portfolio of on-market women’s health products - Annovera (segesterone acetate/ethinyl estradiol), Imvexxy (segesterone acetate/ethinyl estradiol), Bijuva (estradiol and progesterone capsules) – acquired from TherapeuticsMD (Nasdaq: TXMD), as well as pre-natal vitamins. Also contributing was the sale of Metrics Contract Services (MCS) and US Retail GenericsContinued revenue growth of Branded Products was noted, at A$61.9 million in FY 2023 versus A$10.6 million FY 2022 (up 484%) and International A$64.7 million, up 19%. Portfolio products rebounded in the second half of the year, with second half 20223 revenue up 313% from first half 2023.
- Forums
- ASX - By Stock
- Mayne Pharma sees strong sales growth in FY 2023
Shares of Australian specialty pharma firm Mayne Pharma Group...
-
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.38 |
Change
0.000(0.00%) |
Mkt cap ! $372.6M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $4.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.26 | 7 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 4.590 |
1 | 17 | 4.470 |
1 | 125 | 4.400 |
3 | 2963 | 4.380 |
4 | 5709 | 4.370 |
Price($) | Vol. | No. |
---|---|---|
4.170 | 64 | 2 |
4.260 | 7 | 2 |
4.290 | 18 | 2 |
4.380 | 43 | 1 |
4.390 | 639 | 2 |
Last trade - 09.50am 29/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
Day chart unavailable